Prognostic Value of Serum Biomarkers in Patients With Moderate-Severe Traumatic Brain Injury, Differentiated by Marshall Computer Tomography Classification
Journal of Neurotrauma · 2023
DOI: 10.1089/neu.2023.0029 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Neurotrauma, 2023. Verfasst von Sophie Richter und 10 weiteren Autor:innen. Beteiligte Einrichtung: University Division of Anaesthesia, University of Cambridge, Cambridge, United Kingdom. Hauptthemen laut MEDLINE: Brain Injuries, Traumatic. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: Wellcome Trust, Department of Health.
Abstract (Originalsprache)
Prognostication is challenging in patients with traumatic brain injury (TBI) in whom computed tomography (CT) fails to fully explain a low level of consciousness. Serum biomarkers reflect the extent of structural damage in a different way than CT does, but it is unclear whether biomarkers provide additional prognostic value across the range of CT abnormalities. This study aimed to determine the added predictive value of biomarkers, differentiated by imaging severity. This prognostic study used data from the Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury (CENTER-TBI) study (2014–2017). The analysis included patients aged ≥16 years with a moderate-severe TBI (Glasgow Coma Scale [GCS]
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- University Division of Anaesthesia, University of Cambridge, Cambridge, United Kingdom.
- Department of Neurosurgery, Medical School, University of Pécs, Pécs, Hungary.
- Neurotrauma Research Group, Szentágothai Research Centre, University of Pécs, Pécs, Hungary.
- ELKH-PTE Clinical Neuroscience MR Research Group, University of Pécs, Pécs, Hungary.
- Department of Psychology, University of British Columbia, Vancouver, British Columbia, Canada.
- Rehabilitation Research Program, GF Strong Rehabilitation Centre, Vancouver, British Columbia, Canada.
Förderung
- Wellcome Trust
- Department of Health
Zitieren
APA
Richter, S., Czeiter, E., Amrein, K., Mikolic, A., Verheyden, J., Wang, K., Maas, A. I. R., Steyerberg, E., Büki, A., Menon, D. K., & Newcombe, V. F. J. (2023). Prognostic Value of Serum Biomarkers in Patients With Moderate-Severe Traumatic Brain Injury, Differentiated by Marshall Computer Tomography Classification. Journal of Neurotrauma. https://doi.org/10.1089/neu.2023.0029
Vancouver
Richter S, Czeiter E, Amrein K, Mikolic A, Verheyden J, Wang K, et al. Prognostic Value of Serum Biomarkers in Patients With Moderate-Severe Traumatic Brain Injury, Differentiated by Marshall Computer Tomography Classification. Journal of Neurotrauma. 2023. doi:10.1089/neu.2023.0029
BibTeX
@article{Richter2023,
author = {Richter, Sophie and Czeiter, Endre and Amrein, Krisztina and Mikolic, Ana and Verheyden, Jan and Wang, Kevin and Maas, Andrew I R and Steyerberg, Ewout and Büki, András and Menon, David K and Newcombe, Virginia F J},
title = {Prognostic Value of Serum Biomarkers in Patients With Moderate-Severe Traumatic Brain Injury, Differentiated by Marshall Computer Tomography Classification},
journal = {Journal of Neurotrauma},
year = {2023},
doi = {10.1089/neu.2023.0029}
}
EUVIMED